发明申请
US20160031882A1 IMIDAZOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS
审中-公开
作为阿糖胞苷合成酶抑制剂的咪唑吡啶化合物
- 专利标题： IMIDAZOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS
- 专利标题（中）： 作为阿糖胞苷合成酶抑制剂的咪唑吡啶化合物
-
申请号： US14885187申请日： 2015-10-16
-
公开(公告)号： US20160031882A1公开(公告)日： 2016-02-04
- 发明人: Amjad Ali , D. Jonathan Bennett , Jaiqiang Cai , Emma Carswell , Andrew Cooke , Scott B. Hoyt , Michael Lo , Clare London , John MacLean , Min K. Park , Paul Ratcliffe , Jerry Andrew Taylor , Brent Whitehead , Yusheng Xiong
- 申请人： Merck Sharp & Dohme Corp.
- 主分类号： C07D471/04
- IPC分类号： C07D471/04
摘要：
This invention relates to imidazopyridyl compounds of the structural formula: or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase.
公开/授权文献
- US09518055B2 Imidazopyridyl compounds as aldosterone synthase inhibitors 公开/授权日：2016-12-13
信息查询
